177Lu-KBD880

N/A

Report date: 2026/04/22 20:01:10

Base Information

Drug Name177Lu-KBD880

Drug Alias NameN/A

ClassificationRadiation-emitting products > Radionuclide Drug ConjugatesRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radioactive therapeutic agent +[4]

Mechanisms of ActionGlypican-3 modulators

TargetsGlypican-3

Therapy Area/IndicationsCarcinoma, Hepatocellular

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesKangbaida (Sichuan) Biopharmaceutical Technology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesKangbaida (Sichuan) Biopharmaceutical Technology Co Ltd

Inactive CompaniesN/A

Active IndicationsCarcinoma, Hepatocellular

Inactive IndicationsN/A

Other Information

ATC CodeN/A